Trends in Chemoradiation Use in Elderly Patients with Head and Neck Cancer: Changing treatment patterns with cetuximab

BACKGROUND: Cetuximab was approved for use in chemoradiation (CTRT) for locally-advanced head and neck squamous cell carcinoma (HNSCC) in 2006. METHODS: Among 3,705 patients with locally-advanced HNSCC identified in the linked Surveillance Epidemiology and End Results (SEER)-Medicare database, we as...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Head Neck
Asıl Yazarlar: Baxi, Shrujal S., O’Neill, Caitriona, Sherman, Eric J., Atoria, Coral L., Lee, Nancy Y., Pfister, David G., Elkin, Elena B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4970459/
https://ncbi.nlm.nih.gov/pubmed/25535104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.23961
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller